Bone Marrow Leukemic Progenitor Cell Content in Pediatric T-Lineage Acute Lymphoblastic Leukemia Patients with an Isolated Extramedullar First Relapse

References

• Eden O. B., Lilleyman J. S., Richards S., Shaw M. P., Peto J. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood). Br J Haematol 1991; 78: 187–196
   PubMed Web of Science ®Google Scholar
• Kreuger A., Garwicz S., Hertz H., Jonmundsson G., Lanning M., Lie S. O., Moe P. J., Salmi T. T., Schroder H., Siimes M. A., Wesenberg R., Yssing M., Ahstrom L., Gustafsson G. Central nervous system disease in childhood acute lymphoblastic leukemia: prognostic factors and results of treatment. Pediatr Hematol Oncol 1991; 8: 291–299
   PubMed Web of Science ®Google Scholar
• Pui C. H., Simone J. V., Hancock M. L., Evans W. E., Williams D. L., Bowman W. P., Dahl G. V., Dodge R. K., Ochs J., Abromowitch M., Rivera G. Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude total therapy study X. Leukemia 1992; 6: 150–157
   PubMed Web of Science ®Google Scholar
• Rivera G. K., Pinkel D., Simone J. V., Hancock M. L., Crist W. M. Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med 1993; 329: 1289–1295
   PubMed Web of Science ®Google Scholar
• Schaison G., Bancillon A., Baruchel A., Leverger G., Auclerc M. Prognosis of relapses in acute lymphoblastic leukemias of children. Proc An Soc Clin Oncol 1991; 10: 236
   Google Scholar
• Schorin M. A., Blattner S., Gelber R. D., Tarbell N. J., Donnelly M., Dalton V., Cohen H. J., Sallan S. E. Treatmen of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85–01. J Clin Oncol 1994; 12: 740–747
   PubMed Web of Science ®Google Scholar
• Crist W., Boyett J., Jackson J., Jackson J., Vietti T., Borowitz M., Chauvenet A., Winick N., Ragab A., Mahoney D., Head D., Iyer R., Wagner H., Pullen J. Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1989; 74: 1252–1259
   PubMed Web of Science ®Google Scholar
• Ortega J. A., Nesbit M. E., Sather H. N., Robison L. L.G J D. A., Hammond G. D. Long-term evaluation of a CNS prophylaxis trial-treatment comparisons and outcome after CNS relapse in childhood ALL: a report from the Childrens Cancer Study Group. J Clin Oncol 1987; 5: 1646–1654
   PubMed Web of Science ®Google Scholar
• Behrendt H., van Leeuwen E. R., Schuwirth C., Verkes R. J., Hermans J., van der Does-van den Berg A., van Wering E. R. The significance of an isolated central nervous system relapse, occurring as first relapse in children with acute lymphoblastic leukemia. Cancer 1989; 63: 2066–2072
   PubMed Web of Science ®Google Scholar
• Winick N. J., Smith S. D., Shuster J., Lauer S., Wharam M. D., Land V., Buchanan G., Rivera G. Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol 1993; 11: 271–278
   PubMed Web of Science ®Google Scholar
• Bleyer W. A. Biology and pathogenesis of CNS leukemia. Am J Pediatr Hematol Oncol 1989; 11: 157–63
   Google Scholar
• O'Reilly J., Meyer B., Baker D., Herrmann R., Cannell P., Davies J. Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukaemia. Leukemia 1995; 9: 624–627
   PubMed Web of Science ®Google Scholar
• Neale G. A., Pui C. H., Mahmoud H. H., Mirro J., Jr, Crist W. M., Rivera G. K., Goorha R. M. Molecular evidence for minimal residual bone marrow disease in children with “isolated” extra-medullary relapse of T-cell acute lymphoblastic leukemia. Leukemia 1994; 8: 768–775
   PubMed Web of Science ®Google Scholar
• Murray J. C., Gmoser D. J., Barnes D. A., Oshman D., Hawkins H. K., Gresik M. V., Dreyer Z. E. Isolated bone relapse during hematologic remission in childhood acute lymphoblastic leukemia: report of a metatarsal relapse and review of the literature. Med Pediatr Oncol 1994; 23: 153–157
   PubMedGoogle Scholar
• Goulden N., Langlands K., Steward C., Katz F., Potter M., Chessells J., Oakhill A. PCR assessment of bone marrow status in “isolated” extramedullary relapse Of childhood B-pre-cursor acute lymphoblastic leukaemia. Br J Haematol 1994; 87: 282–285
   PubMed Web of Science ®Google Scholar
• Shiramizu B., Campbell L. Early detection of CNS relapse in childhood ALL using PCR. Int J Pediatr Hem Oncol 1995; 1: 605–610
   Google Scholar
• Uckun F. M., Kersey J. H., Haake R., Weisdorf D., Nesbit M. E., Ramsay N. K. Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia. N Engl J Med 1993; 329: 1296–1301
   PubMed Web of Science ®Google Scholar
• Uckun F., Gaynon P., Stram D., Sensel M., Sarquis M., Lazarus K., Willoughby M. Paucity of Leukemic Progenitor Cells in the Bone Marrow of Pediatric B-Lineage Acute Lymphoblastic Leukemia Patients with an Isolated Extramedullary First Relapse. Clin Cancer Res 1999, in press
   Web of Science ®Google Scholar
• Uckun F. M., Muraguchi A., Ledbetter J. A., Kishimoto T. RTOB, Roloff J. S., Gajl Peczalska K., Provisor A., Roller B. Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood 1989; 73: 1000–1015
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Sather H. N., Gaynon P., Arthur D., Trigg M., Tubergen D., Nachman J., Steinherz P., Sensel M., Reaman G. Clinical Features and Treatment Outcome of Children with Myeloid Antigen Positive Acute Lymphoblastic Leukemia: A Report from the Children's Cancer Group. Blood 1997; 90: 28–35
   PubMed Web of Science ®Google Scholar
• Smith M., Arthur D., Camitta B., Carroll A. J., Crist W., Gaynon P., Gelber R., Heerema N., Korn E. L., Link M., Murphy S., Pui C. H., Pullen J., Reamon G., Sallan S. E., Sather H., Shuster J., Simon R., Trigg M., Tubergen D., Uckun F., Ungerleider R. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia [see comments]. J Clin Oncol 1996; 14: 18–24
   PubMed Web of Science ®Google Scholar
• Hutchinson R., Bertolone S., Cooper H., Roskos R., Wells L., Heerema N., Tannous R., Neerhout R., Sather H., Sailer S., Hummell D., Trigg M., Hammond G. Early marrow response predicts outcome for patients with low risk ALL: results of CCG-1881. Proc Amer Soc Clin Oncol 1994; 13: 319
   Google Scholar
• Lange B., Sather H., Weetman R., Bostrom B., McGuire P., Rackhoff W., Arthur D., Trigg M. Double delayed intensification improves outcome in moderate risk pediatric acute lymphoblastic leukemia (ALL): A Children's Cancer Group study, CCG-1891. Blood 1997; 90: 559a
   Google Scholar
• Nachman J. B., Sather H. N., Sensel M. G., Trigg M. E., Cherlo J. M., Lukens J. N., Wolff L., Uckun F. M., Gaynon P. S. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med 1998; 338: 1663–1671
   PubMed Web of Science ®Google Scholar
• Nachman J., Sather H. N., Cherlow J. M., Sensel M. G., Gaynon P. S., Lukens J. N., Wolff L., Trigg M. E. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group. J Clin Oncol 1998; 16: 920–930
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Kersey J. H., Gajl-Peczalska K. J., Heerema N. A., Provisor A. J., Haag D., Gilchrist G., Song C. W., Arthur D. C., Roloff J., Lampkin B., Greenwood M., Dewald G., Vallera D. Heterogeneity of cultured leukemic lymphoid progenitor cells from B cell precursor acute lymphoblastic leukemia (ALL) patients. J Clin Invest 1987; 80: 639–646
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Fauci A. S., Heerema N. A., Song C. W., Mehta S. R., Gajl-Peczalska K., Chandan M., Ambrus J. L. B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells. Blood 1987; 70: 1020–1034
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Song C. W. Radiobiological features of fresh leukemic bone marrow progenitor cells in acute lymphoblastic leukemia. Cancer Res 1988; 48: 5788–5795
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Kersey J. H., Vallera D. A., Ledbetter J. A., Weisdorf D., Myers D. E., Haake R., Ramsay N. K. Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging. Blood 1990; 76: 1723–1733
   PubMed Web of Science ®Google Scholar
• Schroeder H., Garwicz S., Kristinsson J., Siimes M. A., Wesenberg F., Gustafsson G. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO). Med Pediatr Oncol 1995; 25: 372–378
   PubMedGoogle Scholar
• Gaynon P. S., Qu R. P., Chappell R. J., Willoughby M. L., Tubergen D. G., Steinherz P. G., Trigg M. E. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse—the Children's Cancer Group Experience. Cancer 1998; 82: 1387–1395
   PubMed Web of Science ®Google Scholar
• George S. L., Ochs J. J., Mauer A. M., Simone J. V. The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia. J Clin Oncol 1985; 3: 776–781
   PubMed Web of Science ®Google Scholar
• Minicro R., Saracco P., Pastore G., Zurlo M. G., Terracini B., Rosso P., Masera G. Relapse after first cessation of therapy in childhood acute lymphoblastic leukemia: a 10-year follow-up study. Italian Association of Pediatric Hematology-Oncology (AIEOP). Med Pediatr Oncol 1995; 24: 71–76
   PubMedGoogle Scholar
• Henze G., Fengler R., Hartmann R., Kornhuber B., Janka-Schaub G., Niethammer D., Riehm H. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood 1991; 78: 1166–1172
   PubMed Web of Science ®Google Scholar
• Kumar P., Kun L. E., Hustu H. O., Mulhern R. K., Hancock M. L., Coffey D., Rivera G. K. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia [see comments]. Int J Radiat Oncol Biol Phys 1995; 31: 477–483
   PubMed Web of Science ®Google Scholar
• Ribeiro R. C., Rivera G. K., Hudson M., Mulhern R. K., Hancock M. L., Kun L., Mahmoud H., Sandlund J. T., Crist W. M., Pui C. H. An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia. J Clin Oncol 1995; 13: 333–338
   PubMed Web of Science ®Google Scholar
• von der Weid N., Wagner B., Angst R., Arnet B., Baumgartner C., Beck D., Bleher A., Caflisch U., Delaleu B., Feldges A., Frey E., Glanzmann I., Hirt A., Imbach P., Kratel S., Kuchler H., Leidbundgut K., Meister A., Morin A. -M., Nobile L., Pluss H. -J., Luthy A., Signer E., Stettler E., Wyss M., Wagner H. -P. Treatment of relapsing acute lymphoblastic leukemia in childhood. III. Experiences with 54 first bone marrow, nine isolated testicular, and eight isolated central nervous system relapses observed 1985–1989. Med Pediatr Oncol 1994; 22: 361–369
   PubMedGoogle Scholar
• Gelber R. D., Sallan S. E., Cohen H. J., Donnelly M., Dalton V., Tobia F., Clavell L. A., Tarbell N. J. Central nervous system treatment in childhood acute lymphoblastic leukemia, Long-term follow-up of patients diagnosed between 1973 and 1985. Cancer 1993; 72: 261–270
   PubMed Web of Science ®Google Scholar